Timolol Maleate Solution/ Drops
Product Images NDC 64980-513

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Timolol Maleate (NDC 64980-513). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D8c2fa67 7851 40c5 83d6 E82d1903b592 01

FDA Label Image

D8c2fa67 7851 40c5 83d6 E82d1903b592 02

FDA Label Image

D8c2fa67 7851 40c5 83d6 E82d1903b592 03

FDA Label Image

D8c2fa67 7851 40c5 83d6 E82d1903b592 04

This text provides instructions on how to remove the dust cover by turning it clockwise to break the seal. The cover may possibly snap off during the process.*

FDA Label Image

D8c2fa67 7851 40c5 83d6 E82d1903b592 05

FDA Label Image

D8c2fa67 7851 40c5 83d6 E82d1903b592 06

This is a simple instruction for unscrewing the yellow cap.*

FDA Label Image

D8c2fa67 7851 40c5 83d6 E82d1903b592 07

This text provides instructions on how to properly administer eye drops. It advises tilting the head back and pulling down the lower eyelid to create a pocket to dispense the drops into with gentle pressure.*

FDA Label Image

D8c2fa67 7851 40c5 83d6 E82d1903b592 08

This text is a set of instructions for using and taking care of a container. It advises replacing the yellow cap after each use and tightening it securely.*

FDA Label Image

D8c2fa67 7851 40c5 83d6 E82d1903b592 09

This product is for topical application and is used as a sterile ophthalmic. It contains Timolol Maleate equivalent cover, with 10 2.5 mg of Timolol. The container should be stored at 25°C (77°F), and one or two drops should be dispensed in the eyes daily. Protect the container from freezing and light. It is distributed by Rising and manufactured in India. Inactive ingredients include Phamianemonia Injections, Sodium Phosphate, and Dibasic Saddle Brook. Benzalkonium, Chloride 0.01% is added as a preservative. For batch details, check the unpublished area.*

FDA Label Image

D8c2fa67 7851 40c5 83d6 E82d1903b592 10

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.